BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 28133717)

  • 1. Dopamine Increases CD14
    Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.
    Coley JS; Calderon TM; Gaskill PJ; Eugenin EA; Berman JW
    PLoS One; 2015; 10(2):e0117450. PubMed ID: 25647501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.
    Williams DW; Calderon TM; Lopez L; Carvallo-Torres L; Gaskill PJ; Eugenin EA; Morgello S; Berman JW
    PLoS One; 2013; 8(7):e69270. PubMed ID: 23922698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline Science: CXCR7 mediates CD14
    Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
    J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
    Williams DW; Anastos K; Morgello S; Berman JW
    J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14
    Jaureguiberry-Bravo M; Lopez L; Berman JW
    J Leukoc Biol; 2018 Dec; 104(6):1049-1059. PubMed ID: 29791013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2 on Peripheral Blood CD14
    Veenstra M; Byrd DA; Inglese M; Buyukturkoglu K; Williams DW; Fleysher L; Li M; Gama L; León-Rivera R; Calderon TM; Clements JE; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):120-133. PubMed ID: 29981000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.
    Williams DW; Veenstra M; Gaskill PJ; Morgello S; Calderon TM; Berman JW
    Curr HIV Res; 2014; 12(2):85-96. PubMed ID: 24862333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.
    Buckner CM; Calderon TM; Willams DW; Belbin TJ; Berman JW
    Cell Immunol; 2011; 267(2):109-23. PubMed ID: 21292246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.
    Williams DW; Eugenin EA; Calderon TM; Berman JW
    J Leukoc Biol; 2012 Mar; 91(3):401-15. PubMed ID: 22227964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era.
    León-Rivera R; Veenstra M; Donoso M; Tell E; Eugenin EA; Morgello S; Berman JW
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
    Moniuszko M; Liyanage NP; Doster MN; Parks RW; Grubczak K; Lipinska D; McKinnon K; Brown C; Hirsch V; Vaccari M; Gordon S; Pegu P; Fenizia C; Flisiak R; Grzeszczuk A; Dabrowska M; Robert-Guroff M; Silvestri G; Stevenson M; McCune J; Franchini G
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):115-26. PubMed ID: 24432835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
    Man S; Tucky B; Cotleur A; Drazba J; Takeshita Y; Ransohoff RM
    Sci Transl Med; 2012 Feb; 4(119):119ra14. PubMed ID: 22301555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients.
    Han J; Wang B; Han N; Zhao Y; Song C; Feng X; Mao Y; Zhang F; Zhao H; Zeng H
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):553-9. PubMed ID: 19950429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-derived mesenchymal stem cells modulate CD14
    Qiu G; Zheng G; Ge M; Huang L; Tong H; Chen P; Lai D; Hu Y; Cheng B; Shu Q; Xu J
    Stem Cell Res Ther; 2017 Apr; 8(1):97. PubMed ID: 28446249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid CD14
    de Almeida SM; Beltrame MP; Tang B; Rotta I; Abramson I; Vaida F; Schrier R; Ellis RJ
    J Neurovirol; 2023 Jun; 29(3):308-324. PubMed ID: 37219809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD206 and CD163 on intermediate CD14
    Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
    Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.